−1.39USD
−42.94 MUSD
34.89 M
About PDS Biotechnology Corporation
Sector
CEO
Frank K. Bedu-Addo
Headquarters
Princeton
Website
Employees (FY)
25
Founded
2005
ISIN
US70465T1079
FIGI
BBG004NCDK82
PDS Biotechnology Corp. engages in the development of clinical-stage immunotherapies to treat various early-stage and late-stage cancers, including head and neck cancer, prostate cancer, breast cancer, cervical cancer, anal cancer, and other cancers. Its product, PDS0101, is an off the shelf immunotherapeutic that is administered by subcutaneous injection. The company was founded by Frank K. Bedu-Addo in 2005 and is headquartered in Princeton, NJ.
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
Curated watchlists where PDSB is featured.
Frequently Asked Questions
The current price of PDSB is 2.72 USD — it has decreased by 2.86% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange PDS Biotechnology Corporation stocks are traded under the ticker PDSB.
PDS Biotechnology Corporation is going to release the next earnings report on May 14, 2024. Keep track of upcoming events with our Earnings Calendar.
PDSB stock is 5.97% volatile and has beta coefficient of 1.65. Check out the list of the most volatile stocks — is PDS Biotechnology Corporation there?
One year price forecast for PDS Biotechnology Corporation has a max estimate of 21.00 USD and a min estimate of 5.00 USD.
PDSB earnings for the last quarter are −0.35 USD whereas the estimation was −0.45 USD which accounts for 21.47% surprise. Estimated earnings for the next quarter are −0.44 USD. See more details about PDS Biotechnology Corporation earnings.
Yes, you can track PDS Biotechnology Corporation financials in yearly and quarterly reports right on TradingView.
PDSB stock has fallen by 13.38% compared to the previous week, the month change is a 44.38% fall, over the last year PDS Biotechnology Corporation has showed a 60.35% decrease.
PDSB net income for the last quarter is −10.90 M USD, while the quarter before that showed −10.85 M USD of net income which accounts for −0.45% change. Track more PDS Biotechnology Corporation financial stats to get the full picture.
Today PDS Biotechnology Corporation has the market capitalization of 99.77 M, it has decreased by 11.02% over the last week.
No, PDSB doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, PDSB shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade PDS Biotechnology Corporation stock right from TradingView charts — choose your broker and connect to your account.
As of Apr 18, 2024, the company has 25.00 employees. See our rating of the largest employees — is PDS Biotechnology Corporation on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So PDS Biotechnology Corporation technincal analysis shows the strong sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating PDS Biotechnology Corporation stock shows the sell signal. See more of PDS Biotechnology Corporation technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on PDS Biotechnology Corporation future price: according to them, PDSB price has a max estimate of 21.00 USD and a min estimate of 5.00 USD. Read a more detailed PDS Biotechnology Corporation forecast: see what analysts think of PDS Biotechnology Corporation and suggest that you do with its stocks.